secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001104659-23-031371
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa reveals no exposure to Silicon Valley Bank; no deposits or securities held
--------------------------------------------------------------------------------

- Kiniksa confirmed it did not hold cash deposits or securities with SVB.
- Company also stated it has no business relationship with SVB.
- Disclosure made on March 10, 2023, amid SVB liquidity crisis.
- This voluntary FD disclosure reassures investors of zero SVB exposure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000110465923031371/0001104659-23-031371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000110465923031371/tm239243d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-031371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer